GlaxoSmithKline (NYSE:GSK) AIDS drug abacavir holds a hidden key to understanding allergic reactions that some patients experience from other drugs. Abacavir, which is marketed under the name Ziagen, is already known to cause allergic reactions ranging from mild skin irritation to severe allergic shock in certain patients. It can also lead to death. U.S. Food […]
AIDS patients expecting approval of a new HIV-associated diarrhea treatment in June must wait at least another three months for a decision. Salix Pharmaceuticals (NASDAQ:SLXP) had been scheduled for a June 5 decision date on its experimental diarrhea treatment crofelemer. But the Raleigh, North Carolina company said it has been notified by the U.S. Food […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A promising vaccine for the most common serious infection in people with HIV could reach clinical trials next year if it can attract $2.5 million to $3 million in investments this year. MiniVax Inc.’s lead product is MVX-504, a vaccine to prevent the fungal infection Pneumocystis pneumonia (PCP), which often develops in the lungs of […]
An HIV drug candidate developed under a joint venture between GlaxoSmithKline (NYSE:GSK) and Japanese pharmaceutical company Shionogi is showing promise as a contender to take on a blockbuster drug from rival Merck (NYSE:MRK). Initial phase 3 clinical trial results for dolutegravir show the GSK-Shionogi compound matches Merck’s HIV treatment raltegravir. But dolutegravir’s advantage will be […]
AIDS patients who frequently suffer from diarrhea may now finally see some light at the end of the tunnel for a new drug developed to help them. The U.S. Food and Drug Administration has granted priority review for Salix Pharmaceuticals‘ (NASDAQ:SLXP) crofelemer and an approval decision on the drug candidate could come by June 5. […]
Generic competition for GlaxoSmithKline (NYSE:GSK) AIDS drug Epzicom is on its way around the world, if not the United States. Yet. The U.S. Food and Drug Administration has given tentative approval for a formulation of the drug made by Cipla, a pharmaceutical company based in Mumbai, India. The tentative approval comes under expedited review from […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Gastrointestinal therapeutics firm Salix Pharmaceuticals (NASDAQ:SLXP) is pressing ahead with a drug candidate to treat diarrhea in AIDS patients despite a deteriorating relationship with its drug partner that has led to a contract dispute and dueling lawsuits. Raleigh, North Carolina-based Salix today filed a New Drug Application for crofelemer, a filing that comes more than […]
AIDS research efforts at Duke University have landed three grants totaling $37.2 million from the Bill & Melinda Gates Foundation. The grants will fund Duke University Medical Center HIV work in the Collaboration for AIDS Vaccine Discovery (CAVD) program, an international network of scientists working to bring new HIV vaccine candidates into clinical trials. The […]
As a physician, I’ve cared for people living with HIV/AIDS for more than two decades. And as I honor World AIDS this December 1, I’ll remember the many people affected by this disease that have changed my life. Each faced unique challenges and struggles. Many demonstrated remarkable resilience. Everyone reminded me of how quickly life […]
Current medical news from today, including a new HIV vaccine looks promising in animal tests, Onyx Pharmaceuticals rumored to be seeking a buyer, and the many challenges of being a healthcare CEO.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Current medical news from today, including HIV prevention gel for women surprises researchers by failing in a trial, EndoStapling system gets FDA nod, and Supreme Court justices questioned over ethics.
Salix Pharmaceuticals‘ (NASDAQ:SLXP) drug partner Napo Pharmaceuticals has terminated the collaboration agreement between the two companies over Salix’s failure to advance a promising anti-diarrhea drug for AIDS patients fast enough for the California company. Termination of the collaboration to develop the drug candidate crofelemer was effective Nov. 4 — a year to the date of […]
Current medical news from today, including encouraging news for HIV prevention, the Small Business Jobs Act one year later, and tracking how a virus transfers species.
GlaxoSmithKline (NYSE:GSK) is moving to protect its top-selling HIV drug Epzicom from generic drug competition. ViiV Healthcare, the HIV joint venture of GSK and Pfizer (NYSE:PFE), is suing Teva Pharmaceutical (NASDAQ:TEVA) for infringing on HIV drug Epzicom in violation of the drug’s patent, Bloomberg News reports. The Aug. 5 complaint was filed in federal court […]
Immunotherapy company Argos Therapeutics has filed for an initial public stock offering that could raise up to $86.2 million. The Durham, North Carolina-based company has a developed a personalized medicine platform technology whose first target is kidney cancer. CEO Jeff Abbey explained the technology in a MedCity News story that ran in May. The venture […]